

Fundamental dimension Equity attribute | MGNILeader $22.89▼-1.04% Cap $3.28BP/E 19.6x QuantScore53/100 | BOCPeer $12.58▼-0.47% Cap $379.0MP/E -30.0x QuantScore44/100 | CDLXPeer $1.80▼-3.74% Cap $10.60MP/E -0.1x QuantScore22/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
47/100 |
56/100 |
45/100 |
Valuation Multiples, PEG & DCF upside | 68/100 | 17/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 43/100 | 47/100 | 36/100 |
Growth Revenue / earnings growth & margins | 52/100 | 36/100 | 30/100 |
Sentiment Analyst ratings, targets & revisions | 55/100 | 62/100 | 0/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 19.6x | -30.0x | -0.1x |
Forward P/E (next FY) | 20.2x | -157.3x | -0.4x |
EV / EBITDA (TTM) | 19.8x | 23.3x | -2.5x |
Price / Sales | 4.4x | 3.5x | 0.1x |
Price / Free Cash Flow | 15.5x | -53.9x | -2.7x |
PEG ratio | 0.07 | -0.02 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 8 / 9 | 6 / 9 | 4 / 9 |
Altman Z-Score | 1.10 (Distress) | 1.53 (Distress) | -8.80 (Distress) |
Total debt / equity | 0.45 | 0.20 | -11.86 |
Quick ratio | 1.0x | 2.0x | 1.6x |
Interest coverage | 5.2x | -2.1x | -7.9x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +6.9% | +5.6% | -16.2% |
Net income growth YoY | +534.7% | -861.5% | +45.3% |
Gross margin (TTM) | 64.8% | 77.8% | 47.9% |
Operating margin (FY) | 13.7% | -3.4% | -20.2% |
FCF margin (FY) | 23.2% | -8.8% | -2.8% |
5. Trailing price performancePrice change over period |
1M return | -4.9% | -6.3% | -47.8% |
3M return | +23.7% | -11.5% | -50.3% |
6M return | +76.3% | +2.1% | -80.6% |
Year to date | +41.0% | +1.7% | -84.3% |
1Y return | +14.8% | -10.0% | -91.1% |
3Y return | +221.0% | -13.8% | -98.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $13.44 -41.3% premium | $-1.73 -113.7% premium | $-630.06 -35103.2% premium |
Wall Street consensus target | $28.00 +22.3% · range $25.00–$32.00 | $17.00 +35.1% · range $17.00–$17.00 | $1.00 -44.4% · range $1.00–$1.00 |
Consensus stance | 59% Buy28% Hold13% Sell | 50% Buy50% Hold0% Sell | 27% Buy60% Hold13% Sell |